DESLEY BLANCH : When would you be doing Phase 2 and 3 trials?
DR ESRA OGRU : Phase 2 is actually scheduled for later this year and Phase 3 will continue on from the end of this year and all of next year and onwards.
The beauty with working with transtermal systems is the regulatory hurdles are much less complex than developing a novel product and since Oxycodone has been around for a very, very long time, we do have that advantage of knowing what to expect. So we've got a path forward mapped out for the next three to four years and we hope to have it registered by then.
http://www.radioaustralia.net.au/innovations/stories/s2920385.htm
DESLEY BLANCH : When would you be doing Phase 2 and 3 trials?DR...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.226K | 1.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 92468918 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 76402411 | 25 |
View Market Depth
| Last trade - 12.50pm 06/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |